{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(1)"],"submitter":["Wurm S"],"funding":["Austrian Science Fund FWF","Leukämiehilfe Steiermark"],"journal":["Blood cancer journal"],"pagination":["175"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12546751"],"repository":["biostudies-literature"],"pubmed_title":["Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study."],"pmcid":["PMC12546751"],"funding_grant_id":["Grant-DOI 10.55776/PAT1753824","Grant-DOI 10.55776/P36672"],"pubmed_authors":["Moritz JM","Sill H","Mayer DM","Petrasch C","Pregartner G","Groiss C","Schoeche J","Koller E","Eisenwort G","Heine A","Petzer V","Wolf D","Reinisch A","Wurm S","Gleixner KV","Singer J","Machherndl-Spandl S","Sperr WR","Wolfler A","Zebisch A"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-06-04T16:28:04.603Z","creation":"2026-06-02T03:08:51.794Z"},"accession":"S-EPMC12546751","cross_references":{"pubmed":["41125585"],"doi":["10.1038/s41408-025-01396-5"]}}